Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
28 janv. 2019 08h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its...
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
13 déc. 2018 07h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...
Avinger Announces Commercial Launch in Australia
06 déc. 2018 08h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based...
Bottini & Bottini, Inc. Files Securities Class-Action Lawsuit Against Avinger, Inc.
07 juil. 2017 09h00 HE
|
Bottini & Bottini, Inc.
SAN DIEGO, July 07, 2017 (GLOBE NEWSWIRE) -- Bottini & Bottini, Inc., a law firm specializing in securities litigation, announces that it has filed a class-action lawsuit on behalf of all...